Patient(Pt)-reported toxicities during breast cancer (BC) chemotherapy (CRx): Associations with pre-treatment (Tx) measures of quality of life (QOL) and Tx discontinuation.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kirsten A. Nyrop, Allison Mary Deal, Shlomit S. Shachar, Ethan M. Basch, Bryce B. Reeve, Jordan T Lee, Seul Ki Choi, William Allen Wood, Carey K. Anders, Lisa A. Carey, Elizabeth Claire Dees, Trevor Augustus Jolly, Katherine Elizabeth Reeder-Hayes, Gretchen Genevieve Kimmick, Meghan Sri Karuturi, Raquel E. Reinbolt, Joellen C. Speca, Hyman B. Muss
Institutions: UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Duke University, Duke Medical Center, The University of Texas MD Anderson Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2807197496